Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Wearing apparel, fabric, or cloth

Subclass of:

424 - Drug, bio-affecting and body treating compositions

424400000 - PREPARATIONS CHARACTERIZED BY SPECIAL PHYSICAL FORM

Patent class list (only not empty are listed)

Deeper subclasses:

Class / Patent application numberDescriptionNumber of patent applications / Date published
424404000 Antifungal or antibacterial 65
424403000 Insect repellent or mothproofed 12
Entries
DocumentTitleDate
20090123504OLIVE OIL FORMULATION FOR PAIN RELIEF - The present disclosure generally relates to methods and compositions for reducing inflammation and/or pain, and more particularly, to compositions comprising an NSAID and oleocanthal and/or a related compound. The compositions are particularly suitable for topical delivery and may be used to relieve the effects of arthritis.05-14-2009
20080260787Use of Collagen in Combination With Oxygen- and Ozone-Releasing Perfluorocarbons For the Preparation of a Medicament For the Treatment of Skin Lesions - A medicament and a medication for the treatment of skin lesions are disclosed, which comprise collagen and an oxygen-carrying and releasing fluorinated hydrocarbon and, optionally and preferably additionally, ozone. Particularly, the invention relates to a kit for the topical administration of such a medicament on the damaged skin, as well as to a process for preparing the medication.10-23-2008
20090191247Anti-Viral Uses Of Carbon And Metal Nanomaterial Compositions - This invention generally relates to use of novel nanomaterials comprised of metals in anti-viral applications. Such nanomaterials, for example, can be produced using a high power, pulsed plasma process, which plasma process, optionally, can be performed on the metal with a precursor (i.e., a gaseous precursor, such as acetylene or methane) when forming the unagglomerated nanomaterials. In embodiments of the invention, the metal is nanosilver. Optionally, the nanomaterials may also comprise carbon, including in the form of carbyne.07-30-2009
20100150977CAMOMILE TREATED GLOVE - The present invention is directed to a glove wherein the interior surfaces of the glove contain a film which includes water, glycerol and a botanical extract.06-17-2010
20090324664SPRAY-ON, NON-WOVEN FABRIC SYSTEM AND MULTILAYER TOPICAL COVERING - The invention is directed to a spray-on, multilayer, non-woven fabric system and multilayer topical coverings suitable for reducing or alleviating a discomforting condition of the skin and/or an area underlying the skin when applied thereto, where the fabric system includes a first spray-on composition containing a material suitable for reducing or alleviating a discomforting condition of the skin and/or an area underlying the skin when applied thereto, and a second spray-on composition, different from the first spray-on composition for covering the first composition, which includes fibers, a volatile carrier, and a binding agent, and where the multilayer topical covering includes a first layer formed from the first spray-on composition and a second layer covering the first layer, the second layer formed from the second spray-on composition.12-31-2009
20100119564Guided bone regeneration membrane and manufacturing method thereof - Disclosed is a guided bone regeneration membrane including a novel mechanism that effectively induces a bone reconstruction ability. The mechanism is provided by forming a bi-layered structure of a first nonwoven fabric layer containing a silicon-releasable calcium carbonate and a poly(lactic acid) as principal components and a second nonwoven fabric layer containing a poly(lactic acid) as a principal component; and coating the first nonwoven fabric layer with an apatite. The guided bone regeneration membrane is available by using a nonwoven fabric manufacturing technique through electrospinning and a simulated body fluid soaking technique.05-13-2010
20100074931USE OF A HIGHLY EMULSIFIED SILICONE OIL (HES) FOR THE PRODUCTION OF A MEDICAMENT - The invention relates to the use of a silicone oil emulsion comprising 0.01-85 wt. % of silicones, particularly polydimethylsiloxanes, 0.01-90 wt. % of hydrophobic emulsifier that has an HLB value ranging from 1 to 7 and/or a hydrophilic emulsifier that has an HLB value ranging from 7 to 14 and/or 0.01-90 wt. % of a mixture of one or more hydrophobic and hydrophilic emulsifiers having an HLB value ranging from 1 to 14, and 0.1-99 wt. % of biocompatible saline solution, for producing a medicament as such or in combination with other medicaments or carrier materials for treating septic infections triggered by bacterial, viral, parasitic, and fungal causative agents or diseases in animals and humans caused by traumas.03-25-2010
20090110706PAIN RELIEF COMPOSITION AND UTILIZATION THEREOF - A titanium-impregnated tape uses a material treated by fine dispersion water containing citric acid or its salt in which fine metal titanium particles are dispersed. The titanium-impregnated tape provides a physiological structure that acts upon the function to interfere with the pain memory system affecting neurons.04-30-2009
20130084320TISSUE FUSION METHOD USING COLLAGENASE FOR REPAIR OF SOFT TISSUE - The present invention provides a method of using locally administered collagenase as a non-invasive means of enhancing cell release from the cartilage or fibrocartilage tissues adjacent to a disease or injury site. The subsequent migration of cells from these tissues into the lesion or wound, followed by deposition of the appropriate extracellular matrix, results in closure of the lesion or fusion of a tissue gap.04-04-2013
20100266652SLOW RELEASE BIOCIDAL THERMOPLASTIC COMPOSITIONS AND ARTICLES - In one aspect, the invention is directed to a biocidal composition, comprising a mixture of a substantially oxidation-resistant thermoplastic polymer having a melting point of about 60° C. to about 100° C.; and a composition for releasing chlorine dioxide gas upon exposure to moisture and having a bulk density less than about 0.15 g/cc, wherein the mixture of the first thermoplastic polymer and the gas releasing composition has a higher bulk density than gas releasing composition and is a substantially free-flowing non-dusting powder. In another aspect, the invention provides a polymeric matrix comprising the biocidal composition and a second thermoplastic polymer. Both the biocidal composition and the biocidal composition in the polymeric matrix are suitable for commercial manufacture of extruded, injection molded or blow molded articles, films, sheets, and the like.10-21-2010
20090155325FORMULATION AND PRODUCTS FOR PROMOTING SKIN CLEANLINESS AND HEALTH - The present disclosure generally relates to a formulation. More particularly, the formulation may be applied to skin and/or used in combination with a personal care product to improve absorbance and leakage control of the personal care product, and to promote a more positive feel and comfort through improved skin cleanliness and health.06-18-2009
20090155324Skin Treatment System - A skin treatment system includes a flexible panel having an outer surface and an inner surface. The flexible panel may be configured to surround at least a portion of a user's appendage. The skin treatment system may also include at least one skin treatment insert having an inner surface and an outer surface. The flexible panel may be further configured to releasably engage the skin treatment insert. The skin treatment insert may be configured to receive a topical skin treatment. The inner surface of the skin treatment insert may be configured to apply the topical skin treatment to at least a portion of a surface of the user's appendage.06-18-2009
20100104614PROVIDONE COMPOSITIONS FOR WOUND HEALING - Described here are wound dressings and kits. The wound dressings include povidone compositions that may be directly applied to wound surfaces or provided on substrates to form a composite material. The povidone compositions contain a povidone polymer, where the povidone polymer itself is capable of healing wounds. The povidone compositions may be in particulate form. In other instances, the povidone compositions are formulated as gels, ointments, pastes, films, or other topically applied compositions. Methods for applying the povidone compositions to treat wounds are also described.04-29-2010
20090155326LAYERED DRUG DELIVERY POLYMER MONOFILAMENT FIBERS - The present invention is directed generally to a layered polymeric monofilament fiber drug delivery device, where each layer of the device can contain a different polymer, drug, additive, or any combination or mixture thereof. The layered nature of the current monofilament polymeric monofilament device provides the capability to modulate the release of one or more drugs and/or the mechanical properties of the fiber so that drug release and device failure can be separately tuned to provide for the tailored introduction of therapeutically effective drugs or agents to a target tissue. Moreover, the fiber may comprise more than one distinct segments along its length, each segment itself having different combinations and/or numbers of layers thereby providing even greater freedom in the design of the therapeutic delivery device. The invention is also directed to a method of manufacturing such a layered polymeric monofilament fiber drug delivery device, and methods of treatment using such devices.06-18-2009
20100104615ABSORBENT ARTICLE COMPRISING LACTIC ACID PRODUCING BACTERIA - The present invention relates to absorbent articles comprising at least a liquid acquisition layer and an underlying liquid storage layer, said absorbent article comprising lactic acid producing bacteria. The lactic acid producing bacteria are dispersed in a hydrophobic carrier and the article further comprises at least one super-absorbent polymer. At least a part of the total amount of super-absorbent polymer and at least a part of the total amount of the bacteria are present in the liquid storage layer.04-29-2010
20100040655Anti-viral Formulations Nanomaterials And Nanoparticles - The present invention provides the use of nanoparticles of a compound of general formula M02-18-2010
20130045262SEDATIVE FOR EXTERNAL USE, AND SEDATIVE SHEET, AND TEXTILE, CLOTHING, WALL MATERIAL, AND HYPERTHERMIA EQUIPMENT, BRAIN VITALIZATION SHEET, BRAIN VITALIZATION SMALL PILLOW - Disclosed are a sedative for external use, and sedative sheet, and textile, clothing, wall material, and hyperthermia equipment, brain vitalization sheet, brain vitalization small pillow which are with high productivity, adaptive for various shape and various treatment style for patients with pain, and with high treatment effect, comparing with conventional sedative for external use. A sedative for external use 02-21-2013
20130084319BROAD-SPECTRUM ANTIMICROBIAL COMPOSITIONS BASED ON COMBINATIONS OF TAUROLIDINE AND PROTAMINE AND MEDICAL DEVICES CONTAINING SUCH COMPOSITIONS - Novel antimicrobial compositions and coatings are disclosed. The antimicrobial compositions consist of mixtures of taurolidine and protamine, including protamine salts. The antimicrobial compositions are particularly useful in coatings for implantable medical devices. The antimicrobial compositions are effective against a broad spectrum of microbes.04-04-2013
20100092528FRUCTAN-BASED EPILATORY COMPOSITIONS - The invention relates to an epilatory mixture comprising a fructan, preferably inulin. Furthermore, an epilatory composition is disclosed comprising said epilatory effective mixture. Also a method of use of said epilatory composition of the invention for the removal of unwanted hair from the skin is disclosed, as well as a method of use of said composition for carrying out an epilatory treatment which can be carried out by a professional person as well as by a non-professional person.04-15-2010
20090304758Formulations of lipoic acid and hyaluroinc acid and/or the derivatives thereof in the pharmaceutical and cosmetic fields - The present invention relates to novel formulations comprising lipoic acid and hyaluronic acid and/or the derivatives thereof for use in the repair of chronic ulcers, the regeneration of damaged skin, the prevention of skin aging and, when administered by the systemic route, to treat peripheral neuropathies and intoxications by chemical and/or biological agents.12-10-2009
20090117163Composition and Method for the Application of Human Synthetic Pheromones Using Substance Slowly Releasing Technological Bio Capsule in form of Drops in Clothing, Underwear, Jewels and Like - The invention regards a composition for the application of human synthetic pheromones in clothing, underwear, jewels, and like, comprising at least three positive human substances, e.g. androstenone, androstenediol and/or androsterone, said composition being predisposed in said clothing, underwear, jewel or like in such way to be diffused by the user by means of a simple action. The invention regards moreover a method for the application and dispensation of said composition, use of the same composition, to clothing, underwear, jewels and like incorporating the composition and a capsule as a carrier for the same composition.05-07-2009
20130071457Wound Healing Device - The invention is directed to a wound healing device. Such wound healing device utilizes novel wound healing compositions embedded onto or into a natural plant-derived cloth-based matrix.03-21-2013
20090269378USE OF TANNINS IN FILTERS - The present invention relates to the use of a tanning agent in or on filters, in particular natural or synthetic fibrous fabric or foams, for the avoidance of infections, these filters in particular being part of respiratory protection masks or respiratory protection apparatuses.10-29-2009
20090081266SKINCARE MASK PACKET - A skincare mask packet includes a packing bag, a skincare mask, and a skincare liquid packaging unit. An outer edge of the packing bag has a sealing function to form a packet configuration. In addition, the skincare mask is made of materials capable of absorbing liquid. An appropriate amount of skincare liquid is further enclosed in the skincare liquid packaging unit that is accommodated in the packing bag together with the skincare mask. During usage, the packing bag is first pressed or squeezed to break the skincare liquid packaging unit, making the skincare liquid flow out the unit and absorbed by the skincare mask. After the skincare liquid has penetrated into the skincare mask, the packing bag may be sealed off for taking out the skincare mask for a skin care.03-26-2009
20120225108PRODUCTS FOR IMPROVING WOUND HEALING - Morpholino compounds of Formula (I)09-06-2012
20090047317Disinfectant Delivery System and Method of Providing Alcohol-Free Disinfection - A disinfectant delivery system and method of providing alcohol-free disinfection to a body to be disinfected, as well as a method of infection reduction by preparation of a patient before an invasive procedure. A blended cloth comprising first fibers and second fibers is provided with the first fibers generally being greater in quantity by weight than the second fibers. A disinfectant solution impregnates the blended cloth, with the disinfectant solution having chlorhexidine gluconate as an active ingredient and having no alcohol. In the method according to the invention, at least one impregnated blended cloth is used to disinfect at least a portion of a body. A plurality of blended cloths can be provided for disinfecting discrete portions of the body. When an invasive procedure is to be performed on a patient, a further method according to the invention of infection reduction comprises using a CHG-impregnated cloth to disinfect at least a portion of the patient at least one day prior to the invasive procedure proximate the location of the invasive procedure.02-19-2009
20090010978Green tea jewelry - A method for making green tea jewelry is provided. The jewelry may be worn as a transdermal source of green tea components used as an alternative to or in addition to ingestion of green tea liquid or solids. Also provided is a kit for providing green tea jewelry in a substantially water resistant and air-tight package. The kit may comprise additional articles such as informational inserts and scents.01-08-2009
20090010977Insect repellant fabrics having nanocapsules with insecticide - The present invention relates to method of manufacturing a prytheroid-treated fabric and manufactured products created thereby. Through the development and application of prytheroid nanocapsules to a fabric, the fabric exhibits insecticidal properties, even following successive washings and solar exposure.01-08-2009
20120237584SILVER-CONTAINING ANTIMICROBIAL ARTICLES AND METHODS OF MANUFACTURE - A silver composition comprising silver sulfate, methods of making antimicrobial articles, particularly packaged antimicrobial articles, methods of whitening antimicrobial articles, and packaged antimicrobial articles.09-20-2012
20130164360Hemostatic Materials and Devices with Galvanic Particulates - The present invention is directed to a hemostatic material comprising a scaffold and a galvanic particulate. The galvanic particulate comprises particles made of at least two dissimilar metals. The scaffold is preferably a biocompatible polysaccharide-based hemostatic, such as a chitosan or cellulosic based hemostatic like ORC.06-27-2013
20080311165Copper Containing Materials for Treating Wounds, Burns and Other Skin Conditions - The invention provides a method for treating and healing sores, cold sores, cutaneous openings, ulcerations, lesions, abrasions, burns and skin conditions comprising applying to a body surface exhibiting the same, a material incorporating water-in-soluble copper compounds which release cu12-18-2008
20110280919Reinforced Absorbable Synthethic Matrix for Hemostatic Applications - The present invention is directed to a reinforced absorbable hemostat comprising at least one hemostatic agent in a single layer of nonwoven synthetic fabric having a mixture of compressed fiber staples of a polyglycolide/polylactide copolymer and a polydioxanone.11-17-2011
20100310619Sonny's Miracle - An ointment made of sunflower oil and yellow candle (paraffin); the candles are dissolved in the heated sunflower oil container; the yellow candle and sunflower oil mixture turns into a cream which then the ointment is formed, while hot the ointment is pasted on a clean cloth by dipping the cloth into the heated cream mixture; the pasted cloth is kept chilled in the freezer until is ready to be applied; the ointment is applied chilled by applying the pasted cloth into the bum wound and is left on for 10 hours or less, after 10 hours the pasted cloth is replaced with another pasted cloth and the procedure is repeated until the ointment heals the wound, the chilled ointment immediately cools the bum wound and keeps it cool, removes the pain, heals the wound, does not leave wrinkles in the skin12-09-2010
20110217347Antimicrobial films, sponges and sponge cloths - Antimicrobial film based on biopolymers, in particular cellulose and/or protein, or uncoated or coated textile material, and also an antimicrobial sponge or an antimicrobial sponge cloth based on regenerated or precipitated cellulose are provided. The film, the sponge or the sponge cloth is impregnated or coated with at least one α-amino acid ester, the α-amino group of which is acylated with a fatty acid, or the corresponding hydrochloride, and the α-amino acid ester is bound covalently, optionally also ionically, to the film, the sponge or the sponge cloth. The acylated α-amino acid ester is preferably N-lauroyl-L-arginine ethyl ester monohydrochloride (LAECI), N-lauroyl-L-arginine methyl ester monohydrochloride (LAMCI) or N-lauroyl-L-lysine ethyl ester hydrochloride (LLECI). The film is preferably in the form of a flexible tube and is provided as casing for foods, especially sausage products.09-08-2011
20090191248HAND HEALTH AND HYGIENE SYSTEM FOR HAND HEALTH AND INFECTION CONTROL - The present disclosure is directed to a system and methods for maintaining or improving hand health and hygiene. More particularly, the system and methods prevent or overcome skin damage caused by frequent hand washing and use of hand sanitizers and/or cleansers. The hand care system comprises an article, such as an elastomeric glove, that has a moisturizing liquid liner composition on the skin-contacting surface of the article that delivers a skin health benefit to the skin, a non-irritating hand cleanser capable of moisturizing the skin, and a moisturizing hand sanitizer.07-30-2009
20080311166COOLING TOWEL - Absorbent cloths (cooling towels) impregnated with a formulation including purified water, denatured alcohol, Aloe vera, menthol, and at least one scented essential oil, have been developed for quickly and conveniently cooling the skin. A typical cooling towel as described herein is made from 12-18-2008
20100119563SOLID FIBRINOGEN PREPARATION - A fibrinogen preparation is provided which has an improved solubility, may be prepared within a short time and may be used rapidly in clinical set-up. A solid fibrinogen preparation comprising as a main ingredient fibrinogen and further containing the following components: albumin; a nonionic surfactant; a basic amino acid or a salt thereof; and at least two amino acids or a salt thereof selected from an acidic amino acid or a salt thereof and a neutral amino acid or a salt thereof. The solid fibrinogen composition of the present invention may be held on a medical material to form a supporting material holding fibrinogen. Besides, the supporting material holding fibrinogen may be combined with a component comprising as a main ingredient thrombin to provide a fibrin adhesive.05-13-2010
20120087962NOVEL ARTICLE - Aspects of the present invention are directed to personal protection articles, such as protective clothing, articles for sequential contact with multiple users, and cellulosic articles, which have their surface a coating formulation having activity to de-activate pathogenic micro-organisms, the coating comprising an acidic polymer, suitably the polymaleic acid material Gantrez™, a surfactant and an acid. Processes for making such articles, and suitable coating formulations are also disclosed.04-12-2012
20090087465Saline nose wipe and methods of manufacture and use - The present invention generally relates to a wet wipe or sheet that is suitable for contacting the skin and removing mucus from the skin. More specifically, the present invention relates to a wet wipe having an aqueous saline component suitable for dissolving and removing mucus in combination with the fabric matrix of the wet wipe. Typically, the fabric matrix of the wet wipe has a capacity of about 125 grams of solution per square meter, and it is impregnated with the aqueous saline solution to a level at or below approximately 80% of the absorbent capacity of the matrix.04-02-2009
20090291108Fabric with health care component - A fabric includes therapeutic members formed thereon, the therapeutic member comprising powder including Ge, GeO11-26-2009
20090041818ANTIVIRAL AGENT, AND FABRIC AND ANTIVIRAL MEMBER SUPPORTING ANTIVIRAL AGENT - An antiviral agent having been experimentally supported which contains a powder obtained by baking (calcining) dolomite and hydrating a part thereof. Thus, it is possible to provide an antiviral agent which is usable in masks, filters, etc. because of acting directly on viral particles, thus eliminating the infectious capacity of the virus and preventing the invasion of the virus into cells; and a mask and a filter with the use of the antiviral agent.02-12-2009
20080279905Fabric and Clothes for Atopic Dermatitis Patients - To provide a fabric and clothing having a low irritation to patients with atopic dermatitis with high productivity. The fabric is produced as a fabric for patients with atopic dermatitis, which is contactable with an affected area of patients with atopic dermatitis and comprises an ethylene-vinyl alcohol (EVOH)-series fiber comprising an ethylene-vinyl alcohol-series copolymer having an ethylene content of 25 to 70% by mole, in which the surface of the EVOH-series fiber is occupied by the ethylene-vinyl alcohol-series copolymer in a proportion of not less than 70%, wherein the hydroxyl group amount of the EVOH-series fiber surface is 20 to 70% by mole, the Young's modulus of the EVOH-series fiber is not more than 60 cN/dtex, and the single fiber fineness of the EVOH-series fiber is not more than 5 dtex. The EVOH-series fiber may be a sheath-core structure conjugated fiber comprising the EVOH-series copolymer as the sheath component, in particular a sheath-core structure conjugated fiber which comprises the EVOH-series copolymer having an ethylene content of 25 to 70% by mole as the sheath component and a crystalline thermoplastic resin having a melting point of not lower than 150° C. as the core component.11-13-2008
20110206752COMPOSITIONS FOR THE TREATMENT OF PAIN AND/OR INFLAMATION - Compositions for the treatment of pain and/or inflammation comprising at least one peptide with the general formula (I) R1-AA-R2, its stereoisomers, mixtures thereof, and its cosmetically and pharmaceutically acceptable salts. Peptide with general formula (I), its stereoisomers, mixtures thereof, and its cosmetically and pharmaceutically acceptable salts for the treatment of pain and/or inflammation.08-25-2011
20100136072Polymeric Coatings that Inactivate Viruses and Bacteria - Hydrophobic polymeric coatings which can be non-covalently applied to solid surfaces such as metals, plastics, glass, polymers, textiles, and other substrates such as fabrics, gauze, bandages, tissues, and other fibers, in the same manner as paint, for example, by brushing, spraying, or dipping, to make the surfaces virucidal and bactericidal, have been developed.06-03-2010
20090028915Material having antimicrobial activity when wet - An article is applied to the surface of an article, animal housing environment or animal (including humans) to provide antimicrobial activity when activated with a liquid comprising alcohol. The article may comprise a water and/or alcohol absorbent material; and a composition that reacts with water and/or alcohol to produce molecular iodine. The composition provides a local concentration (in the water and/or alcohol) of at least 5 or 10 parts per million iodine in water and/or alcohol carried by the material (that is actual water supported by the water absorbent material) when the material has 5% by weight of water present in the water absorbent.01-29-2009
20090148482Device, System, And Method Comprising Microencapsulated Proton Donor For Release Of Nitric Oxide From A Polymer - A device, comprising an NO eluting polymer is provided. Said device is furthermore provided with microencapsulated liquid (06-11-2009
20090053273Topical medication garment and system and method for providing topical medication - A topical medication garment, a system and a method provide topical medication. An impermeable garment may allow the topical medication to maintain contact with the skin of the user. The garment may prevent the topical medication from absorption into clothing or the undergarment itself. The entirety of the garment may be made from an impermeable material or a portion of the garment may be made from an impermeable material. An impermeable liner may be attached to and/or may be connected to an interior surface of the garment. The garment may have legging portions that reside on the upper thighs of the user when the garment is worn. The legging portions may secure the position of the garment on the user and providing coverage of topical medication applied to the crotch area and upper thighs. The garment may have a structure that resembles a t-shirt.02-26-2009
20090053274DELIVERY SYSTEM FOR A MEDICAMENT OR WELL-BEING ENHANCING COMPOSITION - A delivery system for a medicament or well-being enhancing composition, comprising a flexible member, means for attaching the flexible member to fabric to form a pocket and an absorbent pad for impregnation with the medicament or well-being enhancing composition arranged such that when the flexible member is attached to a piece of fabric a pocket is formed shaped and sized such the pad may be received and held securely within the pocket but is removable therefrom. The fabric is typically part of a garment or bed-linen.02-26-2009
20080317798Disposable Nonwoven Cleansing Mitt - A disposable nonwoven cleansing mitt adapted to be retained on a user's hand during use is provided. The disposable nonwoven cleansing mitt is releasably carrying a personal care composition.12-25-2008
20090252775VIRUCIDAL DISINFECTANT - A virucidal disinfectant having broad-range activity includes an acidic phosphorus compound and/or salt thereof, an alcohol, and one or more polyalkylene glycols. The disinfectant, which may also kill bacteria and/or fungi, may be used for the hygienic disinfection of animate and inanimate surfaces. The invention also provides a disinfection method and a product containing a disinfectant.10-08-2009
20100189755Dryer Sheets and a Method for Treating Skin - The invention relates to substrates impregnated with the skin-treating components which when introduced into a tumbling-type dryer in which it contacts fabric articles, the skin-treating component is transferred to the fabric articles which, when contacted with the skin of a user applies the skin-treating component to human skin.07-29-2010
20090208545SYSTEM AND METHOD FOR PROVIDING MEDICINAL TREATMENT - A medicinal delivery device, system and method for providing medicinal treatment to an area skin. The medicinal delivery device may be configured to be a size and shape suitable to conform to the contours of the body (e.g., the perineum region) and configured to retain the medicant, while allowing transfer of the medicinal properties to the skin. The medicinal delivery system may further comprise a containment structure to contain the medicinal delivery device, hold it in place, provide additional comfort, absorb excess water and/or prevent leakage. The medicinal delivery system may further comprise an activation facilitation device to facilitate preparation of the medicinal delivery device for use.08-20-2009
20100215704METHODS AND PRODUCTS FOR IMPROVING WOUND HEALING - Morpholino compounds of Formula (I)08-26-2010
20090028914MEDICAL DEVICES INCORPORATING COLLAGEN INHIBITORS - Provided herein are implantable or insertable biomedical devices comprising a substrate and a collagen inhibitor on or in said substrate, and methods of treatment using the same. In some embodiments, the device is an absorbable esophageal or tracheal stent. In some embodiments, the device is a vascular stent. Wound closure devices are also provided herein, including a substrate and a collagen inhibitor on or in the substrate. Also provided are surgical packings, including a substrate and a collagen inhibitor on or in the substrate. A barrier material for preventing adhesions in a subject is further provided, including a preformed or in situ formable barrier substrate and a collagen inhibitor on or in the substrate. An ointment comprising a collagen inhibitor is further provided. Kits comprising the coated substrates are also provided.01-29-2009
20100015190Preparation for reducing and/or preventing body fat and respective uses, in particular together with a dressing material - The present invention relates to human metabolism, in particular fat reduction and a cosmetic and pharmaceutical formulation, as well as respective uses in particular together with a dressing material according to the invention.01-21-2010
20090074825COLORANTS BASED N-HALAMINES COMPOSITIONS AND METHOD OF MAKING AND USING - The present invention includes methods, articles, compositions and colorant dyes and pigments that include biocidal N-halamine dye composition having two or more heterocyclic ring structures attached to one or more N-halamine groups, wherein one or more halogens associate with the one or more one or more N-halamine groups to affect biocidal activity.03-19-2009
20090246238REINFORCED ABSORBABLE MULTILAYERED HEMOSTATIC WOUND DRESSING - The present invention is directed to a reinforced absorbable multilayered hemostatic wound dressing comprising a first absorbable nonwoven fabric, a second absorbable woven or knitted fabric, thrombin and/or fibrinogen.10-01-2009
20080311167Topical Composition for Treating Pain - Topical compositions having as the active ingredient a lipid, fatty acid ester, natural wax, sterol, or combinations thereof referred to herein as “lipophilic vehicle” or “LV” and methods of use, have been developed for the amelioration or prevention of pain or the sequelae of pain. The composition may be in the form of an ointment, cream, gel, lotion, spray, foam, paste, patch, suspension or dispersion. In the preferred embodiment, the formulation is a gel. The LV may contain a penetration enhancer, most preferably one with membrane disruptive properties. The formulation may be applied to or impregnated into a gauze, wrap, bandage, cotton-tipped stick, adhesive bandage strip, or other support wrap or medical bandage or wound cover. For example, the compositions may be are incorporated onto or into disposables such as hemorrhoid wipes, sponge, mouth guards, dental trays; needles or catheters; adult diapers; gloves, socks or wrist bands, for ease of application. The composition is applied topically to a site at or adjacent to a painful region. The composition is reapplied as necessary. Pain relief is typically obtained within minutes and lasts for periods of variable duration ranging from minutes to several hours and even, in some cases, days. The composition is variably effective to treat visceral, somatic and neuropathic pain both acute and chronic as well as muscle pain and stiffness and joint pain and stiffness.12-18-2008
20110236448Methods and Apparatus for Passive Reduction of Nosocomial Infections in Clinical Settings, and Fabrics, Yarns, and Filaments for Use in Connection Therewith - A method for passively reducing nosocomial infections by providing fabrics for patient contact only as media for air filtration in areas with patient populations, which fabrics have been treated with a solution of eugenol of sufficient strength and for sufficient time to reduce the percentage of viable microbes in the fabrics by at least 2 log units.09-29-2011
20110117151Device,system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject - A device, a system, or a method is described for treating a disease or a condition of one or more joints of articulating bone in a mammalian subject. The device provides one or more medicaments to one or more joints of the mammalian subject. A device is described that includes one or more substrates configured to contact one or more body contours in proximity to one or more joints of articulating bone of a mammalian subject; one or more sensors configured to monitor movement of the one or more body contours; and one or more applicators supported by the one or more substrates and configured to respond to the movement of the one or more body contours by injecting one or more medicaments to the one or more joint tissues of the mammalian subject.05-19-2011
20110123584Temperature Change Compositions and Tissue Products Providing a Cooling Sensation - Wiping products, such as facial tissues, contain a temperature change composition that can provide a cooling sensation when contacted with the skin of a user. The temperature change composition is structured emulsion that may include a phase change material, a carrier, a surfactant, and a crystalline initiator. The phase change materials, in one embodiment, can have a relatively high heat of fusion. When undergoing a phase change, the temperature change composition absorbs heat and thereby provides a cooling feeling or cooling sensation to the skin of a user.05-26-2011
20130136781REINFORCED ABSORBABLE MULTILAYERED HEMOSTATIC WOUND DRESSING - The present invention is directed to a reinforced absorbable multilayered hemostatic wound dressing comprising a first absorbable nonwoven fabric, a second absorbable woven or knitted fabric, thrombin and/or fibrinogen.05-30-2013
20090186056COMPOSITIONS AND METHODS FOR PREVENTING INFECTION - This invention relates to cholesterol-sequestering agents and methods of using cholesterol-sequestering agents to prevent infection. The compositions of the invention can be used to decontaminate skin and environmental surfaces that are contacted with microorganisms such as envelope viruses.07-23-2009
20110244010Medical devices including medicaments and methods of making and using same - The present invention recognizes that medical devices, such as but not limited to contact lenses, can be made having a coating made at least in part using printing technologies to provide drug storage and drug release structures. The coating preferably includes at least one drug reservoir layer and a least one barrier layer, and can include structures, such as but not limited to capillary structures, that alone or in combination modulate the release of the drug from the coating. One aspect of the present invention is a medical device that incorporates a drug in at least one coating. A second aspect of the present invention is a method of making a medical device that incorporates a drug in at least one coating. A third aspect of the present invention is a method of using a medical device of the present invention to treat or prevent a disease, disorder or condition.10-06-2011
20110086078FIBROUS ANTIMICROBIAL MATERIALS, STRUCTURES, AND BARRIER APPLICATIONS - Fibrous antimicrobial materials for use in structures and barrier applications, such as face masks and wound dressings, have been developed from antimicrobial polymeric materials. The fibrous antimicrobial materials also are particularly suitable for use in air and water filtration. The antimicrobial polymeric materials are prepared from solid solutions of antimicrobial bisguanide compounds blended with certain thermoplastic polymers. The antimicrobial polymeric materials may be extruded into fibers or used in the particulate form for preparation of the nonwoven antimicrobial materials. The antimicrobial bisguanide compound, such as chlorhexidine, are distributed at the molecular level within at least one thermoplastic polymer, such as a polyolefin in which the antimicrobial bisguanide compound is soluble, to form a miscible blend. Methods for their formation and use also are provided.04-14-2011
20110129511PROMOTERS EXHIBITING ENDOTHELIAL CELL SPECIFICITY AND METHODS OF USING SAME FOR REGULATION OF ANGIOGENESIS - Isolated polynucleotide sequences exhibiting endothelial cell specific promoter activity, novel cis regulatory elements and methods of use thereof enabling treatment of diseases characterized by aberrant neovascularization or cell growth are disclosed.06-02-2011
20110086077SILICONE HYDROGELS FOR TISSUE ADHESIVES AND TISSUE DRESSING APPLICATIONS - A silicone hydrogel formulation may contains random and/or block copolymers or oligomers or macromers. The silicone copolymer is copolymerized or blended with other polymers or monomers or macromers to obtain final formulation. The silicone hydrogel may contain crosslinking groups to provide a complete or partially crosslinked final structure. The silicone hydrogel formulation may be pre-formed as a film or other structure, or it may be polymerized during application as in the case of an adhesive formulation. A wound dressing comprising a silicone hydrogel formed as a film, either prior to application to a wound or in situ on a wound, which film has gas permeability, moisture permeability, and high water content, wherein said silicone hydrogel is formed from a polymerizable silicone such as a difunctional polydimethylsiloxane methacrylate and crosslinking agents such as N,N-dimethyllacrylamide (DMA), 2-hydroxyethyl methacrylate (HEMA), and trimethylsiloxy silane (TRIS).04-14-2011
20110081393COOLING SENSATION AGENT COMPOSITION, SENSORY STIMULATION AGENT COMPOSITION AND USE OF THE SAME - Disclosed is a cooling sensation agent composition or sensory stimulation agent composition which contains at least one of diester compounds of dicarboxylic acid represented by the formula (1) wherein A represents CH04-07-2011
20110070277Substrate Comprising A Lotion Composition Limiting the Adherence of Feces or Menses to the Skin - A lotion composition applied on the body facing surface of an absorbent article such as a diaper, training pant, adult incontinence product, feminine hygiene product, improves the ease of removal of feces or menses after an absorbent article comprising the lotion composition has been used and removed from the wearer. The lotion composition may also suitably be applied on a wipe.03-24-2011
20100226948METHODS AND COMPOSITIONS FOR TREATING ACNE - A method for treating acne on the skin. The method has the steps of (a) providing an drapeable or flexible porous article impregnated with an aqueous cleansing composition having a carrier, benzoyl peroxide, and one or more cleansing agents; (b) contacting an area of the skin affected by acne with the porous article such that the skin is contacted by the composition; and (c) removing the composition from the skin wherein residual benzoyl peroxide remains on the skin in an anti-acne effective amount. There are also anti-acne compositions.09-09-2010
20110070276BIOACTIVE KERATIN PEPTIDES - Compositions containing biologically active peptides are disclosed. Active peptides are isolated fragments derived from human hair or sheep wool keratin proteins. Compositions may be prepared for pharmaceutical or topical administration or for use in cosmetic preparations.03-24-2011
20080248074Treatment for Topical Use in Alleviating or Inhibiting Joint Pain or Muscle Pain or Musculoskeletal Pain in a Mammal - A treatment for topical use in alleviating or inhibiting joint pain, muscle pain, or musculoskeletal pain in a mammal. The treatment includes dried nettle plant applied to the skin of a mammal, or includes liquid nettle extract applied to the skin of a mammal, or includes a textile fabric (10-09-2008
20080268007Beauty/medication patch - A beauty/medication patch including a substrate, an outer layer, and a medication lotion; the outer layer being made of a degradable material being disposed on the substrate; one or a plurality of micro-probe array being disposed on a surface of the outer layer; the medication lotion being coated between the substrate and the outer layer, and/or admixed in the substrate; the patch being attached to a human skin, the micro-probe array piercing through a stratum corneum layer of the human skin and naturally being degraded by human skin or absorbed and metabolized by a human body; and the medication lotion penetrating into the skin and being absorbed by the human skin.10-30-2008
20080268006Probiotic Lactobacillus Strains for Improved Vaginal Health - The present invention relates to a probiotic bacterial strain belonging to the genus 10-30-2008
20110165211CARBON DIOXIDE EXTERNAL PREPARATION, AND MATERIAL FOR FORMATION OF CARBON DIOXIDE EXTERNAL PREPARATION - A material for formation of carbon dioxide external preparation of the present invention comprises a base agent and a reactant. The base agent comprises a polymeric three-dimensional network structure impregnated with a viscous material containing at least an acid and water, and is made to contact with the skin in use. The reactant contains at least a carbonate, and contacts with the aforementioned viscous material in use so as to generate carbon dioxide, the carbon dioxide dissolving in the viscous material substantially in a non-bubble state.07-07-2011
20130195945COMPOSITIONS AND METHODS FOR BED BUG CONTROL USING ENTOMOPATHOGENIC FUNGI - Barrier treatment compositions using conidia of entomopathogenic fungi and methods for applying and using the same for bed bug population control and prevention are disclosed. The compositions and methods of the invention provide residual biopesticides control for bed bug populations using barrier treatment compositions transferring conidia of entomopathogenic fungi to a population of bed bugs providing effective kill within about 24 hours to about 10 days. The compositions and methods provide significantly enhanced horizontal transmission of the conidia of the entomopathogenic fungi providing enhanced bed bug control without detrimental effects of bed bug tolerance, resistance and/or negative impact on humans or animals contacting the residual biopesticides.08-01-2013
20110027329Single-use, Disposable Strip For Application Of Topical Compositions - A topical treatment strip comprising a substrate having two surfaces with a topical composition carried thereupon. The treatment strip can be used to treat two surfaces of subject as such as both lips simultaneously. Methods include methods of manufacture and methods of use.02-03-2011
20100322989HYDROPHILIC SKIN CLEANING CLOTH - A preferably single-ply, simply and inexpensively manufacturable hydrophilic skin care tissue for disposable use comprising a textile surface (12-23-2010
20100158964Personal Care Composition Providing Quietness and Softness Enhancement and Articles Using the Same - The present disclosure generally relates to personal care compositions and personal care products. More particularly, the disclosure relates to personal care compositions and personal care products that impart perceivable aesthetic benefits of increased softness, quietness and drapability to the skin or hair of a user. To achieve the perceivable aesthetic benefit, a liquid composition containing water, a skin aesthetic agent selected from fatty acids, fatty alcohols, fatty acid derivatives, fatty alcohol derivatives, and/or combinations thereof, an acidifying agent, and an emulsifying agent may be incorporated into the personal care compositions and personal care products.06-24-2010
20090202601METHOD FOR INHIBITING ONSET OF OR TREATING POLLEN ALLERGY - The intermolecular mutual recognition between a disease-state inducing substance (e.g., allergen group, pathogen et cetera) and a living body which functions at the time when such a disease-state inducing substance reaches the living body is inhibited by making use of pectins and nucleic acids.08-13-2009
20090098173TOPICAL PAIN RELIEF PRODUCT - The present invention is directed to a topical composition comprising a counterirritant active ingredient and a sensate that provides a cooling sensation to the skin that is topically perceptible to an adult human subject for greater than about 90 minutes, e.g. greater than about 120 minutes, say greater than about 150 minutes, when applied in an effective amount over an area on the back of a hand, elbow, lower back or shoulder region. In one embodiment, the sensate can be encapsulated. The sensate can alternatively be bound to an ion exchange resin or adsorbed onto an adsorbant.04-16-2009
20100239625TRANSPARENT ANTIMICROBIAL FACE MASK - A mask for being worn over the nose and mouth of a wearer, and a panel having sufficient transparency to permit visual observation of the mouth of the wearer. The panel is formed from first and second overlying transparent, pleated films perforated with elongate slits sized to permit two-way transit of gases, but not liquids, under atmospheric pressure. The first and second films each include a multitude of projections for maintaining between the first and second films a multitude of tortuous flow paths for permitting respiratory gas flow through the panel.09-23-2010
20080286320Absorbent article comprising a lotion composition for reducing adherence of feces or menses to the skin - The present invention relates to lotion compositions comprised on a body facing surface of an absorbent article such as a diaper, training pants or adult incontinence product. The lotion composition may be used for reducing the adherence of feces or menses to the human skin. The lotion composition comprises at least two compounds wherein one first compound is liquid at 25° C. and at least one second component which is solid at 25° C. An effective amount of the lotion composition is comprised on a body facing surface of an absorbent article which is intended to be worn by a wearer.11-20-2008
20090304759CHITOSAN/SUGAR COMPOSITE FILMS AND LAMINATES MADE THEREFROM - Low-shrinkage chitosan films containing sugars and laminates made from the films are provided. The films and laminates can be used to make a variety of finished articles that can be used to provide protection from hazardous chemical and biological agents.12-10-2009
20110064780POLYMERIC PHEROMONE FORMULATION AND METHOD OF USE TO CALM STRESS-RELATED BEHAVIOR IN MAMMALS OVER AN EXTENDED PERIOD OF TIME - The present invention is directed to a polymeric formulation for controlling animal behavior comprising a low melting point polymer or copolymer, an unsaturated long chain fatty alcohol, and an animal-appeasing pheromone to produce a solid slow release generator of the pheromone. The system is useful for making animal collars and the like.03-17-2011
20090028916Loaded Microspheres - The invention relates to loaded microspheres with a mean diameter of 0.001 to 1 mm, and loaded with one or more absorbed or adsorbed active principles, which are obtained by mixing fine-particle polymethyl methacrylate or methyl methacrylate cross polymer with lipophilic or hydrophilic active principles until they have been absorbed or adsorbed by the surface of the polymer and a dry powder, granules or a paste is obtained. When applied to textile or fiber finishing, the loaded microspheres provide extended release of active cosmetic or pharmaceutical active principles.01-29-2009
20120009236Formable Aquatic Coverings For Preventing Biofouling - The instant invention describes an anti-biofouling structure for placement onto structures or surfaces that are exposed to aquatic environments. Embedded within the anti-biofouling structure are agents that can diffuse out of the structure and prevent the formation and/or accumulation of plant and animal species build-up that creates biofouling. The instant invention also describes a system for preventing biofouling of an object stored in an aquatic environment which includes the anti-biofouling structure, and a protective cover element constructed and arranged to fit various structures, such as boat propellers.01-12-2012
20120009237WOUND HEALING COMPOSITIONS CONTAINING KERATIN BIOMATERIALS - Disclosed are keratin preparations for use in medical applications. Methods of treating wounds are provided, wherein keratin preparations are applied to the wound in a treatment effective amount. Methods of treating burn wounds are also provided. Surgical or paramedic aids are provided, comprising a substrate with keratin preparations provided thereon. Kits comprising keratin derivatives packaged in sterile form are also provided.01-12-2012
20120121678Vapor-Phase Application Of Spinosyn For The Control Of Pest, And Formulations And Products Utilizing The Same - The present invention relates to the vapor-phase application of at least one spinosyn to treat pests including, for example, vadult mosquitoes and houseflies.05-17-2012
20120164201METHOD OF USING COLLOIDAL SILVER AND GOLD ANTI-MICROBIAL ITEMS TO CREATE CLEAN ZONES THEREWITH - Gelatinous foam, coated paper, fabric, and polymer materials combined with the Colloidal Silver or Gold additive to formulate products with anti-microbial surfaces which will then be installed through a process determined by the owner/operator of a multi-person/multi-use facility (with input from the end user) to create anti-microbial areas within the facility. Embodiments of the present invention can be formed from polymer materials with silver or gold additives for creating bacteria-free anti-microbial areas, known as a Clean Zone™, in multi-use or multi-person facilities, such as gyms, hotels, hospitals, doctors' offices, food courts, restaurants, cruise ships, buses, and airplanes. The various embodiments include coated polymer sheets, polymer trays, bamboo and/or cotton towels, rugs and fabric, polymer foam, or polymer mats containing nano-silver or nano-gold in an scheduled and organized manner (with input/requests from the customer) to create permanent or semi-permanent anti-microbial surfaces.06-28-2012
20120164200SUBSTRATES COMPRISING FROTHED BENEFIT AGENTS AND THE METHOD OF MAKING THE SAME - The present invention provides a nonwoven substrate comprising a fibrous web defining a surface; and a layer of a benefit agent wherein said benefit agent is selected from an additive composition, an enhancement component and combinations thereof; wherein said benefit agent is frothed and bonded to the fibrous web surface through a creping process. Additionally, the present invention provides for a method of creping a nonwoven substrate and also provides for a nonwoven substrate comprising an adhesive film of an aqueous, frothed, benefit agent.06-28-2012
20120164199CHEMICALLY AND/OR BIOLOGICALLY REACTIVE COMPOUNDS - This disclosure provides novel compositions comprising an inorganic and organic compound, which provides a means for the indirect attachment of a reactive species, such as an organic reactive molecule, within a binder polymer matrix. Such compositions provide a hydrophilic nanoscale domain that is uniformly dispersed within the polymer matrix. The nanoscale domain comprises inorganic particles having a nanoscale dimension. Such compositions can enhance the performance potential of the re-active species within the polymer material. The polymer composite that results from the introduction of such reactive species into a polymer matrix provides a self-decontaminating feature. The reactive species include those that are capable of associating with a halogen to form a complex that is active in decontamination of chemical or biological agents.06-28-2012
20120213834ISOLATED PON1 POLYPEPTIDES, POLYNUCLEOTIDES ENCODING SAME AND USES THEREOF IN TREATING OR PREVENTING ORGANOPHOSPHATE EXPOSURE ASSOCIATED DAMAGE - An isolated polypeptide comprising the amino acid sequence of serum paraoxonase (PON1) having catalytic efficiency of k08-23-2012
20100172946MATRIX-TYPE TRANSDERMAL DRUG DELIVERY SYSTEM AND PREPARATION METHOD THEREOF - A matrix-type transdermal drug delivery system including capsaicin or a capsaicin derivative as an active component and used for treating neuropathy, pain, and inflammation and a preparation method thereof are provided. The matrix-type transdermal drug delivery system includes: a drug protecting layer; a matrix layer formed on the drug protecting layer and including 0.1-25 wt % of capsaicin or a capsaicin derivative, 40-95 wt % of an adhesive including a water-insoluble acrylic polymer, 1-30 wt % of an alcohol having a molecular weight of 600 Daltons or less, 0.1-20 wt % of a nonionic surfactant, and 0.1-20 wt % of a solubilizing agent including a hydrophilic polymer; and a release liner formed on the matrix layer, and is used for treating neuropathy, pain, or inflammation.07-08-2010
20120076845SALINE NOSE WIPE AND METHODS OF MANUFACTURE AND USE - The present invention generally relates to a wet wipe or sheet that is suitable for contacting the skin and removing mucus from the skin. More specifically, the present invention relates to a wet wipe having an aqueous saline component suitable for dissolving and removing mucus in combination with the fabric matrix of the wet wipe. Typically, the fabric matrix of the wet wipe has a capacity of about 125 grams of solution per square meter, and it is impregnated with the aqueous saline solution to a level at or below approximately 80% of the absorbent capacity of the matrix.03-29-2012
20120315316Reinforced Absorbable Synthetic Matrix For Hemostatic Applications - The present invention is directed to a reinforced absorbable hemostat comprising at least one hemostatic agent in a single layer of nonwoven synthetic fabric having a mixture of compressed fiber staples of a polyglycolide/polylactide copolymer and a polydioxanone.12-13-2012
20120082710METHODS AND COMPOSITIONS FOR TREATING ACNE - A method for treating acne on the skin. The method has the steps of (a) providing an drapeable or flexible porous article impregnated with an aqueous cleansing composition having a carrier, benzoyl peroxide, and one or more cleansing agents; (b) contacting an area of the skin affected by acne with the porous article such that the skin is contacted by the composition; and (c) removing the composition from the skin wherein residual benzoyl peroxide remains on the skin in an anti-acne effective amount. There are also anti-acne compositions.04-05-2012
20110117150Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject - A device, a system, or a method is described for treating a disease or condition of one or more joints of articulating bone in a mammalian subject. A device is described which includes one or more substrates configured to contact one or more body contours at one or more joints of articulating bone of a mammalian subject; and an applicator supported by the one or more substrates and configured to inject one or more medicaments to one or more joint tissues of the mammalian subject.05-19-2011
20110123585Propylene Compositions Containing a Pyrethroid and Products Made Therefrom - Provided are compositions comprising (a) a propylene-alpha-olefin copolymer comprising at least about 50%, by weight of the propylene-alpha-olefin copolymer, of propylene-derived units and about 5% to about 35%, by weight of the propylene-alpha-olefin copolymer, of units derived from at least one of ethylene or a C05-26-2011
20120231060ANTIMICROBIAL HYDROGELS, METHODS OF PREPARATION THEREOF, AND ARTICLES THEREFROM - A covalently crosslinked hydrogel comprises a) three or more divalent poly(alkylene oxide) chains P′ covalently linked at respective first end units to a branched first core group C′, b) three or more divalent poly(alkylene oxide) chains P″ covalently linked at respective first end units to a branched second core group C″, the chains P″ comprising respective second end units which are covalently linked to between 0% and 100% of respective second end units of chains P′ by divalent linking groups L″, and c) at least one pendant cationic block copolymer chain A′-B′. A′-B′ comprises i) a divalent block A′ comprising a poly(alkylene oxide) backbone chain having an end unit covalently linked to a second end unit of one of the chains P′ by a divalent linking group L′, and ii) a monovalent block B′ comprising a first repeat unit, the first repeat unit comprising a backbone carbonate group and a cationic side chain group.09-13-2012
20120263770ANTI-ATOPIC DERMATITIS TEXTILES - The present invention relates to anti-atopic textiles, including a textile body and skin care layers formed by dyeing the textile body with a dyebath, obtained by filtering a mixture of earthworm powder and water through Korean paper. When clothes are made of the anti-atopic textiles and brought in contact with the skin, atopic dermatitis can be significantly alleviated because a moisturizing action and an anti-inflammation action are accelerated by a body composition and fluid components of earthworms included in the skin care layers and paper mulberry extract mixed from Korean paper. The anti-atopic textiles according to the present invention includes a textile body and skin care layers formed by dyeing the textile body with a dyebath which is obtained by mixing earthworm powder, obtained by pulverizing earthworms and drying the pulverized earthworms, and water and then filtering the mixture through Korean paper.10-18-2012
20100255048Web Material - A web material encompasses a bonded fibrous material web of cellulose material that is made of a layer of cellulose fibers that are press-bonded in sections of the fibrous material web. One or several antimicrobial substances are contained in the fibrous material web. The antimicrobial substances are selected from finely dispersed silver and silver salts, antimicrobial metal oxides, solid inorganic acids, solid organic acids, and biocides.10-07-2010
20110159062ANTISEPTIC COMPOSITIONS AND USES THEREOF - Antiseptic compositions and kits containing a source of silver ions and menthol, which act in synergy such that a concentration of silver ions in the composition is substantially reduced, are disclosed. Further disclosed are uses of the antiseptic compositions as disinfectants and in the treatment of wounds.06-30-2011
20080241204WETTING SOLUTION FOR WET WIPES FOR COSMETIC, PERSONAL HYGIENE, DERMATOLOGICAL AND/OR CLEANING PURPOSES - The present invention relates to a wetting solution for manufacturing wet wipes or other wet flexible materials, and to such wet wipes for cosmetic, body care, dermatological and/or cleaning purposes, such as cleaning wipes, facial cleaning wipes, make-up remover wipes, refreshment wipes, baby wipes, wet toilet paper or eyeglass cleaning wipes, wherein the preferably aqueous wetting solution contains at least one amino acid ester, preferably from the group of pyrrolidone carboxylic acid esters, as an emulsifier. The invention further relates to the use of such amino acid esters as emulsifiers in wetting solutions for manufacturing said wet tissues.10-02-2008
20080241203Antiadhesive Kit, Process for Producing the Same and Method of Adhesion Prevention - An adhesion preventive kit and a method of preventing adhesion are provided which have a preventive effect on adhesion in a surrounding part of an edge of an injured or deficient tissue in guided regeneration therapy for an injured tissue. Specifically, the adhesion preventive kit includes: (A) a first membrane of at least two layers having a biodegradable base layer and an adhesion preventive layer provided respectively at outermost surfaces thereof and a second membrane of at least one layer having an adhesion preventive layer provided at an outermost surface thereof, or (B) an adhesion preventive membrane including a biodegradable base layer and an adhesion preventive layer, which membrane has an outermost surface constituted of the adhesion preventive layer and has a tissue sandwiching part.10-02-2008
20130202668Personal Towelette with Cooling Composition for Relief of Heat Symptoms - A cooling composition impregnated on a personal towelette which provides a cooling sensation to the body when wiped across the skin. The application of the towelette containing the cooling composition reduces the symptoms of heat due to hot flashes due to menopause, physical exertion, or high temperatures. The composition provides effective cooling but is mild to the skin since it contains active ingredients in combination with skin soothing compounds. The cooling composition of the present invention is made of a combination of natural herbs and botanicals specifically selected to provide synergistic cooling effects.08-08-2013
20130202669ALBUMIN FIBERS AND FABRICS AND METHODS OF GENERATING AND USING SAME - Provided are method of generating a fiber from a globular protein such as albumin. Also provided are albumin fibers and fabrics and methods of using same for bonding a damaged tissue or for ex vivo or in vivo formation of a tissue.08-08-2013
20130095161COPOLYMERS OF HYDROPHOBIC AND HYDROPHILIC SEGMENTS THAT REDUCE PROTEIN ADSORPTION - The present disclosure relates to compositions A composition comprising a polymerization product of an anionic polysaccharide, a diisocyanate, and a linker, wherein the linker comprises i) an ether group, an ester group, or a combination thereof and, ii) a chain extender comprising a hydroxyl group, a thiol group, an amine group, or a combination thereof. The disclosure further relates to medical devices comprising the aforementioned compositions, and to methods of using the compositions and devices. More particularly, the compositions, devices and methods described herein are useful for preventing protein adhesions in vivo, particularly the Vroman effect.04-18-2013
20130095160RESORBABLE POLYSTATIN BIOMATERIALS - Resorbable biomaterials including polystatin polymers and devices including the resorbable biomaterials are described. Methods of making the resorbable biomaterials and devices including resorbable biomaterials are also described.04-18-2013
20130189338BONE FIBERS HAVING EXTENDED LENGTH - Demineralized bone matrix fibers and demineralized bone compositions are provided. Implantable demineralized bone matrix compositions include elongated bone fibers having an average length from about 2 cm to about 6 cm and an aspect ratio from about 50:1 to about 1000:1. The demineralized bone matrix compositions also include a carrier in an amount sufficient to produce a cohesive formable mass. The elongated fibers can easily entangle to provide an improved demineralized bone matrix having increased osteoconductivity.07-25-2013
20080292670Adhesive and plaster - An adhesive comprising a base with tackiness, an oil and ketoprofen, wherein the adhesive contains no L-menthol, the base is composed at least of a tacky composition comprising an elastomer and a tackifier and/or a tacky polymer containing an unsaturated monomer with a total of 5 or more carbon atoms as the monomer unit, the oil is an oil that is compatible with the tacky composition and the tacky polymer, and the oil content is 150-175 parts by weight with respect to 100 parts by weight as the total of the tacky composition and the tacky polymer.11-27-2008
20120087961HEPATITIS A VIRUCIDE - The invention relates to agents which combat the hepatitus A virus, containing only minimal amounts of chlorine-containing and/or chlorine cleaving active ingredients, or none of said substances. The inventions also relates to the use of these agents and to a method for their production.04-12-2012

Patent applications in class Wearing apparel, fabric, or cloth

Patent applications in all subclasses Wearing apparel, fabric, or cloth